SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : HOT STOCKS 100% 200% 300% profits possible short term

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sly_ who wrote (1209)9/8/1998 9:14:00 AM
From: dexx   of 2038
 
Here is a stock that is at its 52-week low and has some very good news out this morning on Business Wire.

NXTC: NexTech Enterprises

NexTech Enterprises Announces Intention to Acquire DNA Pacifica

Profitable DNA Pacifica Would Distribute NexTech's Nutritional Products Nationwide


LOS ANGELES--(BUSINESS WIRE)-September 8, 1998--NexTech Enterprises International, Inc. announced today it intends to acquire DNA Pacifica, a profitable, privately held nutritional supplement distribution company headquartered near San Diego CA.

Through its numerous offices in California, Arizona, Oregon and New Mexico, DNA Pacifica specializes in providing the highest quality nutritional supplements and supplement regimens to the increasing number of doctors and medical professionals who incorporate nutritional programs into their treatment plans.

Included in DNA's 2,000+ products are NexTech's advanced, trademarked formulations for liquid chelated minerals (Keylation Solution), super-oxygenated water (Bio-Oxygen) and a patented non-invasive intracellular mineral test (Nutri-Probe). DNA also carries proprietary lines of sub-lingual sprays, vitamins, botanicals, homeopathics, ointments, and other over-the-counter preparations.

Additionally, DNA Pacifica offers nutritional counseling and education to professionals, patients and students through DNA's respected seminar programs.

As part of the pending acquisition, DNA Pacifica President Joseph D. Beldonza would continue to supervise DNA's operations and, further, would oversee all distribution of NexTech's products in the United States.

NexTech President Dr. Ronald J. Amen said, "We view the acquisition of DNA Pacifica as a significant addition. As DNA already sells nutritional products in all 50 states, NexTech now is poised to dramatically increase sales of NexTech's advanced nutritional products on a national scale. This is the kind of distribution network we have been actively pursuing."

Mr. Amen noted, "DNA Pacifica is profitable and has positive cash flow. We expect to generate a healthy increase in shareholder value from this new property."

Terms of the acquisition are being negotiated.

NexTech Enterprises International, Inc. (OTC Bulletin Board: NXTC - news) is a multi-industry science and technology company. NexTech manufactures chemical, medical and nutritional products. Subsidiaries of NexTech include Rose Color, Inc. a colorants producer and supplier with facilities in Newark, NJ and India; NexTech Healthcare, a marketer of proprietary healthcare products; and SPS Alfachem, a development/sales company producing fine chemicals and pharmaceutical intermediates, nutraceuticals, herbs and herbal extracts.

This press release contains forward-looking statements with respect to the results of operations and business of the Company that involves risk and uncertainties. The Company's actual future results could materially differ from those discussed. Risks and uncertainties of the Company are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

Contact:

NexTech Enterprises, International
910 Hampshire Road, Suite A
Westlake Village CA 91361

Phone: (805) 496-0301
Fax: (805) 496-0801
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext